Jennifer Kelly
Concepts (116)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Vitamin D | 3 | 2009 | 41 |
Why?
|
Lymphoma, Non-Hodgkin | 3 | 2009 | 41 |
Why?
|
Ultraviolet Rays | 2 | 2009 | 76 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 5 | 2008 | 121 |
Why?
|
Vitamin D Deficiency | 2 | 2009 | 27 |
Why?
|
Caspase 9 | 1 | 2010 | 18 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2010 | 20 |
Why?
|
Tumor Suppressor Proteins | 1 | 2010 | 51 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2010 | 31 |
Why?
|
Burkitt Lymphoma | 1 | 2009 | 36 |
Why?
|
Genetic Predisposition to Disease | 2 | 2010 | 131 |
Why?
|
Lymphoma | 1 | 2010 | 96 |
Why?
|
Repressor Proteins | 1 | 2010 | 96 |
Why?
|
Proto-Oncogene Proteins | 1 | 2010 | 113 |
Why?
|
Carrier Proteins | 1 | 2010 | 177 |
Why?
|
Membrane Proteins | 1 | 2010 | 233 |
Why?
|
Amygdala | 2 | 2002 | 12 |
Why?
|
Signal Transduction | 2 | 2009 | 313 |
Why?
|
Apoptosis | 1 | 2010 | 265 |
Why?
|
Neural Pathways | 2 | 2002 | 48 |
Why?
|
Visual Cortex | 1 | 2003 | 26 |
Why?
|
Risk Factors | 4 | 2009 | 555 |
Why?
|
Case-Control Studies | 2 | 2010 | 283 |
Why?
|
Adult | 8 | 2006 | 1317 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 3 | 2006 | 33 |
Why?
|
Boronic Acids | 2 | 2008 | 16 |
Why?
|
Pyrazines | 2 | 2008 | 20 |
Why?
|
Antineoplastic Agents | 2 | 2006 | 190 |
Why?
|
Middle Aged | 7 | 2006 | 1161 |
Why?
|
Young Adult | 3 | 2010 | 380 |
Why?
|
Humans | 11 | 2006 | 1856 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2010 | 118 |
Why?
|
Evidence-Based Medicine | 2 | 2009 | 125 |
Why?
|
Risk Assessment | 3 | 2009 | 324 |
Why?
|
Nitrogen Mustard Compounds | 1 | 2011 | 10 |
Why?
|
Lymphoma, Mantle-Cell | 1 | 2011 | 7 |
Why?
|
Bronchoalveolar Lavage | 1 | 2010 | 24 |
Why?
|
Bronchoscopy | 1 | 2010 | 27 |
Why?
|
Survival Rate | 2 | 2009 | 250 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2010 | 39 |
Why?
|
Calcifediol | 1 | 2009 | 7 |
Why?
|
Dihydroxycholecalciferols | 1 | 2009 | 8 |
Why?
|
Immunocompromised Host | 1 | 2010 | 70 |
Why?
|
Male | 9 | 2002 | 1553 |
Why?
|
Nutrition Policy | 1 | 2009 | 12 |
Why?
|
Testicular Neoplasms | 1 | 2010 | 26 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2010 | 54 |
Why?
|
Seasons | 1 | 2009 | 64 |
Why?
|
Toll-Like Receptor 9 | 1 | 2009 | 14 |
Why?
|
Dietary Supplements | 1 | 2009 | 34 |
Why?
|
Survivors | 1 | 2010 | 45 |
Why?
|
Female | 8 | 2002 | 1643 |
Why?
|
Lung Diseases | 1 | 2010 | 112 |
Why?
|
Multivariate Analysis | 1 | 2010 | 225 |
Why?
|
Lymphoma, Follicular | 1 | 2009 | 27 |
Why?
|
Logistic Models | 1 | 2010 | 251 |
Why?
|
Treatment Outcome | 3 | 2009 | 661 |
Why?
|
Hodgkin Disease | 1 | 2008 | 46 |
Why?
|
Aged, 80 and over | 2 | 2009 | 599 |
Why?
|
Lymphoma, B-Cell | 1 | 2006 | 33 |
Why?
|
Antibodies, Monoclonal | 2 | 2006 | 241 |
Why?
|
Fluorescent Dyes | 2 | 2002 | 115 |
Why?
|
Aged | 4 | 2006 | 988 |
Why?
|
Amidines | 1 | 2003 | 6 |
Why?
|
Entorhinal Cortex | 1 | 2002 | 6 |
Why?
|
Biotin | 1 | 2002 | 14 |
Why?
|
B-Lymphocytes | 1 | 2006 | 134 |
Why?
|
Macaca fascicularis | 1 | 2002 | 36 |
Why?
|
Macaca mulatta | 1 | 2003 | 71 |
Why?
|
Brain Mapping | 1 | 2003 | 61 |
Why?
|
Cell Differentiation | 1 | 2006 | 262 |
Why?
|
Kaplan-Meier Estimate | 2 | 2010 | 89 |
Why?
|
Disease-Free Survival | 2 | 2009 | 102 |
Why?
|
Iowa | 1 | 2010 | 5 |
Why?
|
Minnesota | 1 | 2010 | 22 |
Why?
|
Genome-Wide Association Study | 1 | 2010 | 8 |
Why?
|
Chromatography, Liquid | 1 | 2010 | 33 |
Why?
|
Platinum Compounds | 1 | 2010 | 7 |
Why?
|
Tandem Mass Spectrometry | 1 | 2010 | 17 |
Why?
|
Paresthesia | 1 | 2010 | 16 |
Why?
|
Renal Insufficiency | 1 | 2010 | 21 |
Why?
|
Infertility, Male | 1 | 2010 | 19 |
Why?
|
Employment | 1 | 2010 | 47 |
Why?
|
Population Surveillance | 1 | 2010 | 70 |
Why?
|
Chemokine CXCL10 | 1 | 2009 | 22 |
Why?
|
Pulmonary Fibrosis | 1 | 2010 | 48 |
Why?
|
Chi-Square Distribution | 1 | 2010 | 179 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2009 | 32 |
Why?
|
Fatigue | 1 | 2010 | 48 |
Why?
|
Proportional Hazards Models | 1 | 2010 | 123 |
Why?
|
Cognition | 1 | 2010 | 97 |
Why?
|
Oligodeoxyribonucleotides | 1 | 2009 | 86 |
Why?
|
Animals | 2 | 2002 | 1031 |
Why?
|
Neoplasms, Second Primary | 1 | 2010 | 31 |
Why?
|
Deoxycytidine | 1 | 2008 | 20 |
Why?
|
Chemokine CCL2 | 1 | 2009 | 57 |
Why?
|
Models, Statistical | 1 | 2010 | 114 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2008 | 61 |
Why?
|
Biological Markers | 1 | 2010 | 262 |
Why?
|
Antigens, CD | 1 | 2009 | 128 |
Why?
|
Interferon-gamma | 1 | 2009 | 133 |
Why?
|
Recurrence | 1 | 2009 | 261 |
Why?
|
Immunophenotyping | 1 | 2006 | 66 |
Why?
|
Tumor Markers, Biological | 1 | 2009 | 112 |
Why?
|
Quality of Life | 1 | 2010 | 188 |
Why?
|
Cardiovascular Diseases | 1 | 2010 | 127 |
Why?
|
Clinical Trials as Topic | 1 | 2010 | 251 |
Why?
|
Proteins | 1 | 2009 | 192 |
Why?
|
Prospective Studies | 1 | 2010 | 545 |
Why?
|
Immunohistochemistry | 1 | 2009 | 355 |
Why?
|
Time Factors | 1 | 2010 | 896 |
Why?
|
Dextrans | 1 | 2002 | 36 |
Why?
|
Phytohemagglutinins | 1 | 2002 | 25 |
Why?
|
Microscopy, Electron | 1 | 2002 | 178 |
Why?
|
Terminology as Topic | 1 | 2002 | 81 |
Why?
|
Neurons | 1 | 2002 | 195 |
Why?
|
